176 related articles for article (PubMed ID: 28293015)
1. Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication.
Lorenc Z; Waniczek D; Lorenc-Podgórska K; Krawczyk W; Domagała M; Majewski M; Mazurek U
Med Sci Monit; 2017 Mar; 23():1305-1311. PubMed ID: 28293015
[TBL] [Abstract][Full Text] [Related]
2. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
[TBL] [Abstract][Full Text] [Related]
3. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
Wieczorek E; Jablonowski Z; Tomasik B; Konecki T; Jablonska E; Gromadzinska J; Fendler W; Sosnowski M; Wasowicz W; Reszka E
Clin Biochem; 2015 Dec; 48(18):1235-40. PubMed ID: 26197083
[TBL] [Abstract][Full Text] [Related]
4. Expression of Migration-Related Genes in Human Colorectal Cancer and Activity of a Disintegrin and Metalloproteinase 17.
Walkiewicz K; Kozieł P; Bednarczyk M; Błażelonis A; Mazurek U; Muc-Wierzgoń M
Biomed Res Int; 2016; 2016():8208904. PubMed ID: 27110571
[TBL] [Abstract][Full Text] [Related]
5. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
6. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
7. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
[TBL] [Abstract][Full Text] [Related]
8. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
Soini Y; Satta J; Määttä M; Autio-Harmainen H
J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
[TBL] [Abstract][Full Text] [Related]
9. High variability in MMP2/TIMP2 and MMP9/TIMP1 expression in secondary liver tumors.
Avădanei R; Căruntu ID; Amălinei C; Lozneanu L; Balan R; Grigoraş A; Ciobanu Apostol D; Giuşcă SE
Rom J Morphol Embryol; 2013; 54(3):479-85. PubMed ID: 24068394
[TBL] [Abstract][Full Text] [Related]
10. mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor.
Scrideli CA; Cortez MA; Yunes JA; Queiróz RG; Valera ET; da Mata JF; Toledo SR; Pavoni-Ferreira P; Lee ML; Petrilli AS; Brandalise SR; Tone LG
Leuk Res; 2010 Jan; 34(1):32-7. PubMed ID: 19875168
[TBL] [Abstract][Full Text] [Related]
11. MMP9 overexpression is associated with good surgical outcome in children with UPJO: Preliminary results.
Reis ST; Leite KRM; Viana NI; Lopes RI; Moura CM; Ivanovic RF; Machado M; Denes FT; Giron A; Nahas WC; Srougi M; Passerotti CC
BMC Urol; 2016 Jul; 16(1):44. PubMed ID: 27448803
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of tissue inhibitor of metalloproteinase-1 gene correlates with poor outcomes in colorectal cancer.
Inagaki D; Oshima T; Yoshihara K; Tamura S; Kanazawa A; Yamada T; Yamamoto N; Sato T; Shiozawa M; Morinaga S; Akaike M; Fujii S; Numata K; Kunisaki C; Rino Y; Tanaka K; Masuda M; Imada T
Anticancer Res; 2010 Oct; 30(10):4127-30. PubMed ID: 21036730
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR.
Simi L; Andreani M; Davini F; Janni A; Pazzagli M; Serio M; Orlando C
Lung Cancer; 2004 Aug; 45(2):171-9. PubMed ID: 15246188
[TBL] [Abstract][Full Text] [Related]
14. TUC.338 promotes invasion and metastasis in colorectal cancer.
Wang C; Wang Z; Zhou J; Liu S; Wu C; Huang C; Ding Y
Int J Cancer; 2017 Mar; 140(6):1457-1464. PubMed ID: 27914101
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Suzuki M; Iizasa T; Fujisawa T; Baba M; Yamaguchi Y; Kimura H; Suzuki H
Invasion Metastasis; 1998-1999; 18(3):134-41. PubMed ID: 10474026
[TBL] [Abstract][Full Text] [Related]
17. Expression and Influence of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 and Vascular Endothelial Growth Factor in Diabetic Foot Ulcers.
Li G; Zou X; Zhu Y; Zhang J; Zhou L; Wang D; Li B; Chen Z
Int J Low Extrem Wounds; 2017 Mar; 16(1):6-13. PubMed ID: 28682675
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer.
Yang XZ; Cui SZ; Zeng LS; Cheng TT; Li XX; Chi J; Wang R; Zheng XF; Wang HY
Aging (Albany NY); 2017 Mar; 9(3):914-931. PubMed ID: 28316326
[TBL] [Abstract][Full Text] [Related]
20. Is determination of matrix metalloproteinases and their tissue inhibitors serum concentrations useful in patients with gastroenteropancreatic and bronchopulmonary neuroendocrine neoplasms?
Blicharz-Dorniak J; Kos-Kudła B; Foltyn W; Kajdaniuk D; Marek B; Zemczak A; Strzelczyk J
Endokrynol Pol; 2012; 63(6):470-6. PubMed ID: 23339005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
